BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 28395217)

  • 1. Novel alkylated azoles as potent antifungals.
    Shrestha SK; Garzan A; Garneau-Tsodikova S
    Eur J Med Chem; 2017 Jun; 133():309-318. PubMed ID: 28395217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents.
    Thamban Chandrika N; Shrestha SK; Ngo HX; Tsodikov OV; Howard KC; Garneau-Tsodikova S
    J Med Chem; 2018 Jan; 61(1):158-173. PubMed ID: 29256601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections.
    Holbrook SYL; Garzan A; Dennis EK; Shrestha SK; Garneau-Tsodikova S
    Eur J Med Chem; 2017 Oct; 139():12-21. PubMed ID: 28797882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel fluconazole derivatives with promising antifungal activity.
    Thamban Chandrika N; Shrestha SK; Ngo HX; Howard KC; Garneau-Tsodikova S
    Bioorg Med Chem; 2018 Feb; 26(3):573-580. PubMed ID: 29279242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New azoles with potent antifungal activity: design, synthesis and molecular docking.
    Che X; Sheng C; Wang W; Cao Y; Xu Y; Ji H; Dong G; Miao Z; Yao J; Zhang W
    Eur J Med Chem; 2009 Oct; 44(10):4218-26. PubMed ID: 19539408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of resistance to azole antifungals.
    Lupetti A; Danesi R; Campa M; Del Tacca M; Kelly S
    Trends Mol Med; 2002 Feb; 8(2):76-81. PubMed ID: 11815273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New azoles with antifungal activity: Design, synthesis, and molecular docking.
    Chai X; Zhang J; Cao Y; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q
    Bioorg Med Chem Lett; 2011 Jan; 21(2):686-9. PubMed ID: 21190856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
    Malik MA; Lone SA; Gull P; Dar OA; Wani MY; Ahmad A; Hashmi AA
    Med Chem; 2019; 15(6):648-658. PubMed ID: 30501599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New miconazole-based azoles derived from eugenol show activity against Candida spp. and Cryptococcus gattii by inhibiting the fungal ergosterol biosynthesis.
    Campos Péret VA; Reis RCFM; Braga SFP; Benedetti MD; Caldas IS; Carvalho DT; Santana LFA; Johann S; Souza TB
    Eur J Med Chem; 2023 Aug; 256():115436. PubMed ID: 37146343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents.
    Emami S; Foroumadi A; Falahati M; Lotfali E; Rajabalian S; Ebrahimi SA; Farahyar S; Shafiee A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):141-6. PubMed ID: 18032039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
    Yu PK; Moron-Espiritu LS; Lao AR
    mSystems; 2022 Dec; 7(6):e0069122. PubMed ID: 36383015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combating fluconazole-resistant fungi with novel β-azole-phenylacetone derivatives.
    Zhao L; Sun N; Tian L; Sun Y; Chen Y; Wang X; Zhao S; Su X; Zhao D; Cheng M
    Eur J Med Chem; 2019 Dec; 183():111689. PubMed ID: 31541871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening.
    Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S
    Eur J Med Chem; 2019 Oct; 179():634-648. PubMed ID: 31279296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new, broad-spectrum azole antifungal: posaconazole--mechanisms of action and resistance, spectrum of activity.
    Hof H
    Mycoses; 2006; 49 Suppl 1():2-6. PubMed ID: 16961575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azole derivatives with naphthalene showing potent antifungal effects against planktonic and biofilm forms of Candida spp.: an in vitro and in silico study.
    Sari S; Koçak E; Kart D; Özdemir Z; Acar MF; Sayoğlu B; Karakurt A; Dalkara S
    Int Microbiol; 2021 Jan; 24(1):93-102. PubMed ID: 32889579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies.
    Doğan İS; Saraç S; Sari S; Kart D; Eşsiz Gökhan Ş; Vural İ; Dalkara S
    Eur J Med Chem; 2017 Apr; 130():124-138. PubMed ID: 28242548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medically important fungi respond to azole drugs: an update.
    Zavrel M; White TC
    Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives.
    Xu Y; Sheng C; Wang W; Che X; Cao Y; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W
    Bioorg Med Chem Lett; 2010 May; 20(9):2942-5. PubMed ID: 20362444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of highly potent novel antifungal azoles by structure-based rational design.
    Wang W; Sheng C; Che X; Ji H; Cao Y; Miao Z; Yao J; Zhang W
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5965-9. PubMed ID: 19748782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.